Form 4: GeoVax Labs CFO Mark Reynolds Reports Purchase of Common Stock
SEC Form 4 Filing
GeoVax Labs CFO Mark Reynolds reported purchasing 6,800 shares of common stock at $1.0799 per share on March 31, 2025.
Summary
- On March 31, 2025, Mark Reynolds, the CFO of GeoVax Labs, Inc. [GOVX], filed a Form 4.
- The form reports a transaction where Reynolds purchased 6,800 shares of GeoVax Labs common stock.
- The purchase price was $1.0799 per share.
- Following the transaction, Reynolds directly owns 14,013 shares of GeoVax Labs common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CFO's purchase of shares is a positive sign, but the scale of the purchase is not large enough to significantly impact sentiment.
Positives
- The CFO's purchase of company stock could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.
Stakeholder Impact
- The stock purchase by the CFO may have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of the stock purchase transaction and filing date of the Form 4. |
Keywords
Form 4, GeoVax Labs, GOVX, Mark Reynolds, CFO, Stock Purchase, Common Stock, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.